Acasti Pharma Inc (ACST)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Acasti Pharma Inc (ACST) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013144
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月27日
◆ページ数:41
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Acasti Pharma Inc (Acasti), a subsidiary of Neptune Technologies & Bioressources Inc is a biopharmaceutical company that offers research, development and commercialization of prescription drugs. The company offers products such as Onemia and CaPre. Its CaPre is developed for the prevention and treatment of cardiometabolic disorders including, hypertriglyceridemia. Acasti’s Onemia is an active ingredient used for clinical dietary management of cardiometabolic disorders. The company’s products are used in the therapeutic areas of hyperlipidemia, atherosclerosis, diabetes, rheumatoid arthritis, and gastroenterology disorders. It conducts market research studies through collaborations with KOLs, high volume prescribers and pharmacies. Acasti is headquartered in Laval, Quebec, Canada.

Acasti Pharma Inc (ACST) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Acasti Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Acasti Pharma Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Acasti Pharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Acasti Pharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Acasti Pharma Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Acasti Pharma Inc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Acasti Pharma to Enter into Agreement with China-Based Pharmaceutical Company 10
Xymogen Enters Into Distribution Agreement With Acasti Pharm For LipiChol540 11
Equity Offering 12
Acasti Pharma Files Registration Statement to Raise of up to USD17.2 Million in Public Offering of Shares 12
Acasti Pharma Raises USD4.3 Million in Public Offering of Units 13
Acasti Pharma Prices Public Offering of Units for Upto USD6 Million 15
Acasti Pharma Completes Private Placement Of Units For US$2 Million 17
Acasti Pharma Completes Public Offering Of Units For US$23 Million 18
Acasti Pharma Completes Private Placement Of Units For US$1 Million 20
Acasti Pharma Completes Private Placement Of Shares For US$1 Million 21
Acasti Pharma Completes Rights Offering Of Common Stock For US$8.3 Million 22
Debt Offering 23
Acasti Pharma Raises USD1.5 Million in Private Placement of 8% Debentures and Warrants Due 2020 23
Acasti Pharma Inc – Key Competitors 25
Acasti Pharma Inc – Key Employees 26
Acasti Pharma Inc – Locations And Subsidiaries 27
Head Office 27
Recent Developments 28
Financial Announcements 28
Aug 14, 2017: Acasti Pharma Reports First Quarter FY 2018 Financial Results 28
Jun 06, 2017: Acasti Pharma Reports Fourth Quarter and Full-Year 2017 Financial Results 29
Jan 12, 2017: Acasti Pharma Reports Third Quarter 2017 Financial Results 31
Oct 11, 2016: Acasti Pharma Reports Second Quarter 2017 Financial Results 32
Jul 11, 2016: Acasti Announces First Quarter Results 33
May 25, 2016: Acasti Pharma Announces Fourth Quarter and Fiscal Year Results 34
Jan 12, 2016: Acasti Announces Third Quarter Results 35
Corporate Communications 36
Nov 16, 2017: Acasti Pharma Announces the Election of Its Directors 36
Nov 28, 2016: Acasti Pharma names CFO 37
May 12, 2016: Jan D’Alvise Appointed President & CEO of Acasti Pharma 38
Mar 25, 2016: Nasdaq Grants Acasti Cure Period to Regain Compliance with Audit Committee Membership Requirements 39
Mar 01, 2016: Acasti Announces Management Appointment and Changes to the Board of Directors 40
Appendix 41
Methodology 41
About GlobalData 41
Contact Us 41
Disclaimer 41

List of Tables
Acasti Pharma Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Acasti Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Acasti Pharma Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Acasti Pharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Acasti Pharma Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Acasti Pharma Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Acasti Pharma to Enter into Agreement with China-Based Pharmaceutical Company 10
Xymogen Enters Into Distribution Agreement With Acasti Pharm For LipiChol540 11
Acasti Pharma Files Registration Statement to Raise of up to USD17.2 Million in Public Offering of Shares 12
Acasti Pharma Raises USD4.3 Million in Public Offering of Units 13
Acasti Pharma Prices Public Offering of Units for Upto USD6 Million 15
Acasti Pharma Completes Private Placement Of Units For US$2 Million 17
Acasti Pharma Completes Public Offering Of Units For US$23 Million 18
Acasti Pharma Completes Private Placement Of Units For US$1 Million 20
Acasti Pharma Completes Private Placement Of Shares For US$1 Million 21
Acasti Pharma Completes Rights Offering Of Common Stock For US$8.3 Million 22
Acasti Pharma Raises USD1.5 Million in Private Placement of 8% Debentures and Warrants Due 2020 23
Acasti Pharma Inc, Key Competitors 25
Acasti Pharma Inc, Key Employees 26

★海外企業調査レポート[Acasti Pharma Inc (ACST)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Panasonic Homes Co., Ltd.:企業の戦略的SWOT分析
    Panasonic Homes Co., Ltd. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Jyoti Structures Ltd (JYOTISTRUC):企業の財務・戦略的SWOT分析
    Jyoti Structures Ltd (JYOTISTRUC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Caterpillar Inc (CAT)-エネルギー分野:企業M&A・提携分析
    Summary Caterpillar Inc. (Caterpillar) is a manufacturer of construction, transportation and energy equipment. It designs, manufactures, markets and sells construction and mining equipment, industrial gas turbines, forestry machinery, diesel and natural gas engines, and diesel-electric locomotives. …
  • Saint-Gobain Weber GmbH:企業の戦略・SWOT・財務分析
    Saint-Gobain Weber GmbH - Strategy, SWOT and Corporate Finance Report Summary Saint-Gobain Weber GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • VSB Holding GmbH-エネルギー分野:企業M&A・提携分析
    Summary VSB Holding GmbH (VSB), formerly WSB Neue Energien GmbH is a renewable energy company that offers solutions for renewable energy projects. The company offers services such as wind energy services, photovoltaics services, investments and wind park management. It provides wind energy services …
  • QUALCOMM Incorporated:企業の戦略・SWOT・財務情報
    QUALCOMM Incorporated - Strategy, SWOT and Corporate Finance Report Summary QUALCOMM Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Fortis Healthcare Ltd (FORTIS):製薬・医療:M&Aディール及び事業提携情報
    Summary Fortis Healthcare Ltd (Fortis) is an integrated healthcare provider that delivers healthcare services in the Pan Asia-Pacific region. The company’s services portfolio comprises diagnostics, primary care, day care and specialty hospitals. It owns, operates, and manages a chain of multi-specia …
  • Northwest Territories Power Corp:企業の発電所・SWOT分析2018
    Northwest Territories Power Corp - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on …
  • InspireMD Inc (NSPR)-医療機器分野:企業M&A・提携分析
    Summary InspireMD Inc (InspireMD), formerly Saguaro Resources Inc is a medical device company that develops and commercializes stent platform MGuard technology. The company’s products include carotid embolic prevention system, Mguard embolic prevention system and Mguard prime. Its MGuard is based on …
  • Teijin Limited:企業のM&A・事業提携・投資動向
    Teijin Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Teijin Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • Air France-KLM SA:企業の戦略・SWOT・財務情報
    Air France-KLM SA - Strategy, SWOT and Corporate Finance Report Summary Air France-KLM SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • QDVC Q.S.C:企業の戦略的SWOT分析
    QDVC Q.S.C - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Midatech Pharma Plc (MTPH):製薬・医療:M&Aディール及び事業提携情報
    Summary Midatech Pharma Plc (Midatech) is a pharmaceutical company that develops and commercializes products in oncology and other therapeutic areas. The company’s products include gelclair, oravig, soltamox and zuplenz. It conducts research and development programs in the areas of oncology, autoimm …
  • City National Wealth Management:企業の戦略・SWOT・財務分析
    City National Wealth Management - Strategy, SWOT and Corporate Finance Report Summary City National Wealth Management - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Acuity Brands Inc (AYI):企業の財務・戦略的SWOT分析
    Acuity Brands Inc (AYI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Dell Technologies Inc (DVMT):医療機器:M&Aディール及び事業提携情報
    Summary Dell Technologies, Inc. (Dell), is a provider of desktop personal computers, software and peripherals. The company designs, develops, manufactures, markets, sells and supports information technology infrastructure such as laptops, desktops, mobiles, workstations, storage devices and printers …
  • Altimmune Inc-製薬・医療分野:企業M&A・提携分析
    Summary Altimmune Inc (Altimmune), formerly Vaxin Inc is a biotechnology company that develops vaccines and other biological products. The company's products include novel vaccine delivery platforms, immunotherapeutic products, intranasally administered recombinant influenza vaccine, traditional inf …
  • SGD S.A.:企業の戦略・SWOT・財務情報
    SGD S.A. - Strategy, SWOT and Corporate Finance Report Summary SGD S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Difference Capital Financial Inc.:企業のM&A・事業提携・投資動向
    Difference Capital Financial Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Difference Capital Financial Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mer …
  • AMETEK Inc (AME):企業の財務・戦略的SWOT分析
    Summary AMETEK Inc (AMETEK) is an electronic products manufacturer. The company manufactures electronic instruments and electromechanical devices. Its product portfolio includes medical materials, motion control systems, sub assemblies and connectors, electrical cord reels, gauges, titanium alloys a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆